This article, sponsored by Avista Healthcare Partners, discusses the shift from “generalist” to “specialist” approaches in healthcare private equity, emphasizing the need for deep sector expertise to ensure successful investments. David Burgstahler, CEO of Avista, highlights the firm’s nearly 30-year history in healthcare, focusing on mid-market product and technology investments, leading to sustainable growth. Avista’s strategy involves collaboration with seasoned operating partners and maintaining a narrow focus on six subsectors. The firm prioritizes regulatory compliance and transparency, fostering relationships with regulators to navigate challenges, ultimately achieving significant financial returns through its specialized approach.